Clinical Trial Co. Owner Admits Lying To FDA

The co-owner of a Miami clinical trial company pled guilty on Wednesday to lying to federal regulators investigating an alleged scheme to falsify research records and score contracts with drug developers....

Already a subscriber? Click here to view full article